246.712 INFORMATION REQUIRED TO BE GIVEN TO INDIVIDUALS.
Subdivision 1.
Information to patient. (a) Before seeking any consent required by the
procedures under sections
246.71 to
246.722, a secure treatment facility shall inform the patient
that the patient's bloodborne pathogen test results, without the patient's name or other uniquely
identifying information, shall be reported to the employee if requested and that test results
collected under sections
246.71 to
246.722 are for medical purposes as set forth in section
246.718
and may not be used as evidence in any criminal proceedings or civil proceedings, except for
procedures under sections
144.4171 to
144.4186.
(b) The secure treatment facility shall inform the patient of the insurance protections in
section
72A.20, subdivision 29.
(c) The secure treatment facility shall inform the patient that the patient may refuse to
provide a blood sample and that the patient's refusal may result in a request for a court order to
require the patient to provide a blood sample.
(d) The secure treatment facility shall inform the patient that the secure treatment facility
will advise the employee of a secure treatment facility of the confidentiality requirements and
penalties before the employee's health care provider discloses any test results.
Subd. 2.
Information to secure treatment facility employee. (a) Before disclosing any
information about the patient, the secure treatment facility shall inform the employee of a secure
treatment facility of the confidentiality requirements of section
246.719 and that the person may be
subject to penalties for unauthorized release of test results about the patient under section
246.72.
(b) The secure treatment facility shall inform the employee of the insurance protections
in section
72A.20, subdivision 29.
History: 2000 c 422 s 42